2 active not recruiting, 2 completed. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Active not recruiting 2, Completed 2 |
| Phase 1 | 1 | Active not recruiting 1 |
Follow Cancer of Lung: new trials by email Literature Review of Cancer of Lung trials Research Report on Cancer of Lung
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation JDQ443, TNO155, tislelizumab - KRAS G12C Mutant Solid Tumors, Carcinoma, Non-Small-Cell Lung | Phase 1 / Phase 2 | Active not recruiting | Novartis Pharmaceuticals | 344 | 2021-02-24 | 2026-10-19 |
| Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma UV1 vaccine + leukine, ipilimumab, nivolumab - Cancer, Cancer, Lung | Phase 2 | Active not recruiting | Åslaug Helland | 118 | 2020-05-04 | 2024-02-29 |
| Study of Arsenic Trioxide in Small Cell Lung Cancer Arsenic Trioxide - Lung Cancer, Cancer of Lung | Phase 2 | Completed | Emory University | 20 | 2011-08-01 | 2021-02-17 |
| LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With Chemotherapy YM155 - Lung Cancer, Cancer of Lung | Phase 2 | Completed | Astellas Pharma Inc | 37 | 2006-12-01 | 2008-01-02 |
Lung Neoplasms (4) · Carcinoma, Non-Small-Cell Lung (2) · Carcinoma, Small Cell (1) · Colorectal Neoplasms (1) · Mesothelioma (1) · Mesothelioma, Malignant (1) · Neoplasm Metastasis (1) · Neoplasms (1)
Lung Diseases (4) · Neoplasms by Site (4) · Respiratory Tract Diseases (4) · Respiratory Tract Neoplasms (4) · Thoracic Neoplasms (4) · Neoplasms (3) · Bronchial Neoplasms (2) · Carcinoma, Bronchogenic (2) · Neoplasms by Histologic Type (2) · Neoplasms, Glandular and Epithelial (2) · Adenoma (1) · Carcinoma (1) · Colonic Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1)
Arsenic Trioxide (1) · Ipilimumab (1) · JDQ443 (1) · Nivolumab (1) · UV1 vaccine (1) · sargramostim (1) · sepantronium (1) · tislelizumab (1)
Astellas Pharma Inc (1) · Emory University (1) · Novartis Pharmaceuticals (1) · Åslaug Helland (1)
Australia (2) · Denmark (2) · Germany (2) · Netherlands (2) · Spain (2) · United States (2) · Belgium (1) · Canada (1) · China (1) · Czechia (1) · France (1) · Hong Kong (1) · Italy (1) · Japan (1) · Norway (1)
Taofeek Owonikoko, MD, PhD (1)
PMID 27142472, PMID 34059094, PMID 36399068, PMID 39133306, PMID 42322509
K23CA164015 (1)